Feedback
Fanconi Anemia, Group C (FANCC), 2 Variants
0051468
Ordering Recommendation

Carrier screening or diagnostic testing for Fanconi anemia group C for individuals of Ashkenazi Jewish descent.

Mnemonic
FANCC
Methodology
Polymerase Chain Reaction/Fluorescence Monitoring
Performed
Tue, Fri
Reported
5-10 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Lavender (EDTA), pink (K2EDTA), or yellow (ACD Solution A or B). 
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL) 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
Plasma or serum. Specimens collected in sodium heparin or lithium heparin tubes. 
Remarks
 
Stability
Ambient: 72 hours; Refrigerated: 2 weeks; Frozen: 1 month 
Reference Interval
By report
Interpretive Data
Background information for Fanconi Anemia, Group C (FANCC), 2 Variants:
Characteristics:
Fanconi anemia, group C is characterized by the following symptoms:short stature, abnormal skin pigmentation, and multiple malformations that may affect eyes, ears, heart, oral cavity, thumbs, forearms, kidneys, or urinary tract. Other symptoms may include hearing loss, hypogonadism, and developmental delay. Progressive bone marrow failure occurs during the first decade of life. Hematologic malignancies occur in approximately 20 percent of affected individuals. Nonhematologic malignancies occur in approximately 30 percent of affected individuals.
Incidence:
1 in 32,000 Ashkenazi Jewish individuals.
Inheritance:
Autosomal recessive.
Cause:
FANCC pathogenic variants.
Variants Tested:
p.D23Ifs (c.67delG) and c.456+4A>T.
Clinical Sensitivity:
99 percent in Ashkenazi Jewish individuals, unknown in other ethnicities.
Methodology:
Polymerase chain reaction (PCR) and fluorescence monitoring.
Analytical Sensitivity and Specificity:
Greater than 99 percent.
Limitations:
Variants other than p.D23Ifs (c.67delG) and c.456+4A>T will not be detected. Diagnostic errors can occur due to rare sequence variations.

Compliance Statement C: The performance characteristics of this test were validated by ARUP Laboratories. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test. However, FDA approval or clearance is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. ARUP is authorized under Clinical Laboratory Improvement Amendments (CLIA) and by all states to perform high-complexity testing. Counseling and informed consent are recommended for genetic testing. Consent forms are available online.

Note
CPT Code(s)
81242
Components
Component Test Code*Component Chart NameLOINC
0051470Fanconi Anemia C (FANCC), Allele 1
0051472Fanconi Anemia C (FANCC), Interp
0051474Fanconi Anemia C (FANCC), Allele 2
2001309Fanconi Anemia C (FANCC), Specimen
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Fanconi anemia, complementation group C